We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Amplitude Surgical | EU:AMPLI | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.08 | -2.67% | 2.92 | 2.90 | 2.98 | 3.02 | 2.92 | 3.02 | 2,603 | 16:40:00 |
Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME plans), a leading French player on the surgical technology market for lower-limb orthopedics, announces its sales for the first half of its 2021-22 financial year.
Olivier Jallabert, Amplitude Surgical’s CEO, commented: “During the first half of our 2021-22 financial year, Amplitude Surgical recorded a 3.9% increase in sales at constant exchange rates. Knee and hip activity was stable compared with the previous year and continues to be negatively affected by the public health situation associated with the COVID-19 pandemic, with further health restrictions and cancelled operations as well as the reduced availability of operating rooms and medical staff. Novastep, meanwhile, has continued its development and now accounts for approximately 16.4% of the Group’s total sales, with growth of almost 33% over the period.”
Sales by activity
H1 2021-22 sales
31/12/2021
31/12/2020
Change at current exchange rates
Change at constant exchange rates
In thousands of euros - IFRS
Knee and hip activity
40,187
40,072
0.3%
-0.3%
Feet and ankles (Novastep)
7,912
5,838
35.5%
33.1%
Total
48,099
45,910
4.8%
3.9%
Q2 2021-22 sales
31/12/2021
31/12/2020
Change at current exchange rates
Change at constant exchange rates
In thousands of euros - IFRS
Knee and hip activity
23,150
20,892
10.8%
10.3%
Feet and ankles (Novastep)
4,760
3,435
38.6%
34.7%
Total
27,910
24,327
14.7%
13.7%
In the first half of its 2021-22 financial year (from July to December 2021), Amplitude generated sales of €48.1 million, up 4.8% in actual terms and 3.9% at constant exchange rates.
Sales by geographical region
H1 2021-22 sales
31/12/2021
31/12/2020
Change at current exchange rates
Change at constant exchange rates
In thousands of euros - IFRS
France
30,502
29,615
3.0%
3.0%
International
17,597
16,295
8.0%
5.6%
o/w subsidiaries
13,825
12,457
11.0%
7.9%
o/w distributors
3,771
3,839
-1.7%
-1.7%
Total
48,099
45,910
4.8%
3.9%
Q2 2021-22 sales
31/12/2021
31/12/2020
Change at current exchange rates
Change at constant exchange rates
In thousands of euros - IFRS
France
18,241
15,468
17.9%
17.9%
International
9,669
8,859
9.1%
6.4%
o/w subsidiaries
7,550
6,938
8.8%
5.3%
o/w distributors
2,119
1,921
10.3%
10.3%
Total
27,910
24,327
14.7%
13.7%
By geographical region, sales evolved as follows:
Next financial press release H1 2021-22 results, on Wednesday March 23, 2022, after market.
About Amplitude Surgical Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents distributing its products in more than 30 countries. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. At June 30, 2021, Amplitude Surgical had a workforce of 443 employees and recorded sales of nearly 95.5 million euros.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220216005961/en/
Amplitude Surgical Dimitri Borchtch CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41
NewCap Investor Relations Mathilde Bohin/Thomas Grojean amplitude@newcap.eu +33 (0)1 44 71 94 94
NewCap Media Relations Nicolas Merigeau amplitude@newcap.eu +33 (0)1 44 71 94 98
1 Year Amplitude Surgical Chart |
1 Month Amplitude Surgical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions